181 related articles for article (PubMed ID: 31270933)
1. A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerations.
Huber C; Benda N; Friede T
Pharm Stat; 2019 Oct; 18(5):600-626. PubMed ID: 31270933
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Subgroup identification for treatment selection in biomarker adaptive design.
Lu TP; Chen JJ
BMC Med Res Methodol; 2015 Dec; 15():105. PubMed ID: 26646831
[TBL] [Abstract][Full Text] [Related]
4. Model-Based Recursive Partitioning for Subgroup Analyses.
Seibold H; Zeileis A; Hothorn T
Int J Biostat; 2016 May; 12(1):45-63. PubMed ID: 27227717
[TBL] [Abstract][Full Text] [Related]
5. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G
Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102
[TBL] [Abstract][Full Text] [Related]
6. Detecting treatment-subgroup interactions in clustered data with generalized linear mixed-effects model trees.
Fokkema M; Smits N; Zeileis A; Hothorn T; Kelderman H
Behav Res Methods; 2018 Oct; 50(5):2016-2034. PubMed ID: 29071652
[TBL] [Abstract][Full Text] [Related]
7. Multiplicity-adjusted semiparametric benefiting subgroup identification in clinical trials.
Schnell PM; Müller P; Tang Q; Carlin BP
Clin Trials; 2018 Feb; 15(1):75-86. PubMed ID: 29035083
[TBL] [Abstract][Full Text] [Related]
8. Advancing cancer drug development through precision medicine and innovative designs.
Zhang W; Wang J; Menon S
J Biopharm Stat; 2018; 28(2):229-244. PubMed ID: 29173004
[TBL] [Abstract][Full Text] [Related]
9. Precision medicine: Subgroup identification in longitudinal trajectories.
Wei Y; Liu L; Su X; Zhao L; Jiang H
Stat Methods Med Res; 2020 Sep; 29(9):2603-2616. PubMed ID: 32070237
[TBL] [Abstract][Full Text] [Related]
10. A promising subgroup identification method based on a genetic algorithm for censored survival data.
Zhao L; Zhang W; Wu Y; Cao L; Wang L; Li K
J Biopharm Stat; 2024 Jan; 34(1):55-77. PubMed ID: 36727221
[TBL] [Abstract][Full Text] [Related]
11. Change plane model averaging for subgroup identification.
Liu P; Li J; Kosorok MR
Stat Methods Med Res; 2023 Apr; 32(4):773-788. PubMed ID: 36775991
[TBL] [Abstract][Full Text] [Related]
12. PSICA: Decision trees for probabilistic subgroup identification with categorical treatments.
Sysoev O; Bartoszek K; Ekström EC; Ekholm Selling K
Stat Med; 2019 Sep; 38(22):4436-4452. PubMed ID: 31246349
[TBL] [Abstract][Full Text] [Related]
13. ASIED: a Bayesian adaptive subgroup-identification enrichment design.
Xu Y; Constantine F; Yuan Y; Pritchett YL
J Biopharm Stat; 2020 Jul; 30(4):623-638. PubMed ID: 31782938
[TBL] [Abstract][Full Text] [Related]
14. Ensemble survival trees for identifying subpopulations in personalized medicine.
Chen YC; Chen JJ
Biom J; 2016 Sep; 58(5):1151-63. PubMed ID: 27073016
[TBL] [Abstract][Full Text] [Related]
15. Exploratory identification of predictive biomarkers in randomized trials with normal endpoints.
Krzykalla J; Benner A; Kopp-Schneider A
Stat Med; 2020 Mar; 39(7):923-939. PubMed ID: 31863499
[TBL] [Abstract][Full Text] [Related]
16. Identification of drug-induced toxicity biomarkers for treatment determination.
Lu TP; Chen JJ
Pharm Stat; 2015; 14(4):284-93. PubMed ID: 25914330
[TBL] [Abstract][Full Text] [Related]
17. Subgroup identification in dose-finding trials via model-based recursive partitioning.
Thomas M; Bornkamp B; Seibold H
Stat Med; 2018 May; 37(10):1608-1624. PubMed ID: 29388228
[TBL] [Abstract][Full Text] [Related]
18. Look before you leap: systematic evaluation of tree-based statistical methods in subgroup identification.
Liu Y; Ma X; Zhang D; Geng L; Wang X; Zheng W; Chen MH
J Biopharm Stat; 2019; 29(6):1082-1102. PubMed ID: 30859903
[TBL] [Abstract][Full Text] [Related]
19. Biomarker threshold adaptive designs for survival endpoints.
Diao G; Dong J; Zeng D; Ke C; Rong A; Ibrahim JG
J Biopharm Stat; 2018; 28(6):1038-1054. PubMed ID: 29436940
[TBL] [Abstract][Full Text] [Related]
20. A nonparametric method for value function guided subgroup identification via gradient tree boosting for censored survival data.
Zhang P; Ma J; Chen X; Shentu Y
Stat Med; 2020 Dec; 39(28):4133-4146. PubMed ID: 32786155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
